ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Adam E. Saltman
Irvin B. Krukenkamp
Sidney Levitsky
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Saltman, A. E.
Right arrow Articles by Levitsky, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saltman, A. E.
Right arrow Articles by Levitsky, S.

Ann Thorac Surg 2000;70:595-601
© 2000 The Society of Thoracic Surgeons


Original articles: cardiovascular

Pharmacological preconditioning with the adenosine triphosphate–sensitive potassium channel opener pinacidil

Adam E. Saltman, MD, PhDa, Irvin B. Krukenkamp, MDa, Glenn R. Gaudette, MSca, Hitoshi Horimoto, MDa, Sidney Levitsky, MDb

a Division of Cardiothoracic Surgery, University Hospital at Stony Brook and the State University of New York, Stony Brook, New York, USA
b Division of Cardiothoracic Surgery, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA

Address reprint requests to Dr Saltman, Division of Cardiothoracic Surgery, State University of New York at Stony Brook, T19, 080 Health Sciences Center, Stony Brook, NY 11794-8191
e-mail: saltman{at}surg.som.sunysb.edu

Background. Ischemic preconditioning (IPC) decreases infarct size after global or regional ischemia. Potassium channel openers also precondition but are subject to dose-limiting vasodilation. We compared the mechanical and electrophysiological effects of ischemic and pharmacological preconditioning in an isolated rabbit heart model.

Methods. Rabbit hearts were preconditioned with either 10 µmol/L pinacidil alone (P-), 10 µmol/L pinacidil with 10 µmol/L phenylephrine (P+), or two cycles of global ischemia and reperfusion (IPC) before 1 hour of LAD occlusion. Left ventricular pressure, epicardial monophasic action potential duration (APD) and coronary flow were monitored throughout. Infarct size was determined at the end of reperfusion.

Results. Regional ischemia uniformly decreased APD (p < 0.05). During reperfusion, APDs were prolonged beyond preischemic values in all preconditioned groups (p < 0.05). P- and P+ reduced the incidence of fibrillation. P- significantly increased coronary flow (+15%, p = 0.001), whereas IPC and P+ did not. However, IPC and P- significantly decreased systolic function (p < 0.05) but P+ did not. In addition, IPC depressed diastolic function (p < 0.05) but P- and P+ did not. Infarct size was reduced by all methods (p < 0.05).

Conclusions. Pinacidil presents a safe and effective alternative to IPC for preserving the heart during regional ischemia. Its coronary vasodilatory effects are safely and effectively reversed by the addition of phenylephrine.




This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
A. E. Saltman, T. O. Aksehirli, V. Valiunas, G. R. Gaudette, N. Matsuyama, P. Brink, and I. B. Krukenkamp
Gap junction uncoupling protects the heart against ischemia
J. Thorac. Cardiovasc. Surg., August 1, 2002; 124(2): 371 - 376.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. Coromilas, C. Costeas, B. Deruyter, S. M. Dillon, N. S. Peters, and A. L. Wit
Effects of Pinacidil on Electrophysiological Properties of Epicardial Border Zone of Healing Canine Infarcts: Possible Effects of KATP Channel Activation
Circulation, May 14, 2002; 105(19): 2309 - 2317.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
R. M. Mentzer Jr
Ischemic preconditioning: how close are we to therapeutic implementation?
Ann. Thorac. Surg., August 1, 2000; 70(2): 356 - 357.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2000 by The Society of Thoracic Surgeons.